[1] Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements. J Gastroenterol Hepatol, 2010, 25:657-663. [2] Verhelst X, Dias AM, Colombel J, et al. Protein Glycosylation as a Diagnostic and Prognostic Marker of Chronic Inflammatory Gastrointestinal and Liver Diseases. Gastroenterology, 2020, 158:95-110. [3] 中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版). 临床肝胆病杂志, 2020, 36:277-292. [4] Holst S, Wuhrer M, Rombouts Y. Glycosylation characteristics of colorectal cancer. Adv Cancer Res, 2015, 126:203-256. [5] Ebeling FG, Stieber P, Untch M, et al. Serum CEA and CA 15-3 as prognostic factors in primary breast cancer. Br J Cancer, 2002, 86:1217-1222. [6] Zurawski VR, Orjaseter H, Andersen A, et al. Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: Relevance for early detection of ovarian cancer. Int J Cancer, 1988, 42:677-680. [7] Gilgunn S, Conroy PJ, Saldova R, et al. Aberrant PSA glycosylation--a sweet predictor of prostate cancer. Nat Rev Urol, 2013, 10:99-107. [8] Callewaert N, Vlierberghe HV, Hecke AV, et al. Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat Med, 2004, 10:429-434. [9] Liu XE, Desmyter L, Gao CF, et al. N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus. Hepatology, 2007, 46:1426-1435. [10] Chen C, Schmilovitz-Weiss H, Liu XE, et al. Serum protein N-glycans profiling for the discovery of potential biomarkers for nonalcoholic steatohepatitis. J Proteome Res, 2009, 8:463-470. [11] Fang M, Zhao Y, Zhou F, et al. N-glycan based models improve diagnostic efficacies in hepatitis B virus-related hepatocellular carcinoma. Int J Cancer, 2010, 127:148-159. [12] Cao X, Shang Q, Chi X, et al. Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus. World J Gastroenterol, 2020, 26:1067-1079. [13] Goldman R, Ressom HW, Varghese RS, et al. Detection of hepatocellular carcinoma using glycomic analysis. Clin Cancer Res, 2009, 15:1808-1813. |